Kangjian Miaomiao (Hangzhou) Pharmaceutical Co., Ltd. announced that it has raised CNY 100 million in a round of funding on June 19, 2024. The transaction included participation from new investors Shanghai Kindly Enterprise Development Group Co.,LTD.,Xianju Blue Bay Health Industry Investment Partnership (Limited Partnership),Hangzhou Yika Venture Capital Fund Partnership (Limited Partnership) and returning investor Korea Investment Partners (Shanghai) Venture Capital Management Co., Ltd.